查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1521400

全球抗感染剂市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Anti-Infective Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 175 Pages | 商品交期: 最快1-2个工作天内

价格

全球抗感染药物市场需求预计将从2023年的1,747亿美元达到2032年近2,038.6亿美元的市场规模，2024-2032年研究期间复合年增长率为1.73%。

抗感染剂是用于预防和治疗各种病原体（包括病毒、细菌、真菌和寄生虫）引起的感染的药物。它们包括抗生素、抗病毒药物、抗真菌药物和抗寄生虫药物。这些药剂透过抑制感染性生物体的生长或杀死感染性生物体发挥作用。抗感染药物的选择取决于感染类型、致病病原体和患者的健康状况。正确使用这些药物对于防止抗药性的产生、确保有效治疗感染和维护公众健康至关重要。

市场动态

细菌、病毒、真菌和寄生虫感染的发生率不断上升，需要开发和使用有效的抗感染药物。医学研究的进步催生了新型抗生素、抗病毒药物、抗真菌药物和抗寄生虫药，解决了抗药性菌株并改善了治疗结果。人们越来越认识到早期和适当的感染治疗的重要性，这也刺激了需求。此外，扩大发展中地区的医疗基础设施和提高医疗服务的可近性也发挥着至关重要的作用。政府的支持措施和对传染病研究的资助进一步刺激了市场。院内感染发生率的增加凸显了对有效抗感染药物的需求。製药公司对研发、策略合作伙伴关係和药物开发合作的投资加速了新型和先进抗感染药物的推出，推动了市场成长。然而，抗药性菌株的出现和治疗的副作用可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球抗感染药物市场的各个细分市场进行了包容性评估。抗感染剂产业的成长和趋势为本研究提供了整体方法。

市场区隔

抗感染药物市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型/药物类别

  • 抗菌药（头孢菌素类、青霉素类、氟喹诺酮类、大环内酯类、碳青霉烯类等）
  • 抗病毒药
  • 抗霉菌药（唑类、棘白菌素类、多烯类、其他）

依给药途径

  • 专题
  • 口服
  • 四号
  • 其他的

按配销通路

  • 医院药房
  • 零售药局
  • 专业药房
  • 电子商务
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲抗感染药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。抗感染药物市场的主要参与者包括辉瑞公司、雅培公司、吉利德科学公司、百时美施贵宝公司、默克公司、山德士国际有限公司、贝朗公司、Xellia Pharmaceuticals、Mankind Pharma、拜耳股份公司、阿斯特捷利康、勃林格殷格翰国际有限公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：抗感染剂 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型/药品类别进行的市场吸引力分析
    • 按给药途径进行的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球抗感染药物市场分析：按类型/药物类别

  • 按类型/药物类别概述
  • 按类型/药物类别进行历史和预测资料分析
  • 抗菌药（头孢菌素类、青霉素类、氟喹诺酮类、大环内酯类、碳青霉烯类等）
  • 抗病毒药
  • 抗霉菌药（唑类、棘白菌素类、多烯类、其他）

第 6 章：全球抗感染药物市场分析：依给药途径

  • 依给药途径概述
  • 按给药途径进行历史和预测资料分析
  • 专题
  • 口服
  • 四号
  • 其他的

第 7 章：全球抗感染药物市场分析：按分销管道

  • 配销通路概述
  • 按配销通路进行历史和预测资料分析
  • 医院药房
  • 零售药局
  • 专业药房
  • 电子商务
  • 其他的

第 8 章：全球抗感染药物市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：抗感染药物公司的竞争格局

  • 抗感染药物市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Pfizer Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Gilead Sciences Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bristol-Myers Squibb Company
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck & Co. Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sandoz International GmbH
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • B. Braun SE
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Xellia Pharmaceuticals
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Mankind Pharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bayer AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AstraZeneca
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Boehringer Ingelheim International GmbH
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112115203

The global demand for Anti-Infective Agents Market is presumed to reach the market size of nearly USD 203.86 Billion by 2032 from USD 174.7 Billion in 2023 with a CAGR of 1.73% under the study period 2024-2032.

Anti-infective agents are medications used to prevent and treat infections caused by various pathogens, including viruses, bacteria, fungi, and parasites. They include antibiotics, antivirals, antifungals, and antiparasitic drugs. These agents work by inhibiting the growth of or killing infectious organisms. The choice of anti-infective agent depends on the type of infection, the causative pathogen, and the patient's health condition. Proper use of these agents is essential to prevent the development of resistance, ensure effective treatment of infections, and safeguard public health.

MARKET DYNAMICS

The rising incidence of bacterial, viral, fungal, and parasitic infections necessitates the development and availability of effective anti-infective agents. Advances in medical research have led to the creation of novel antibiotics, antivirals, antifungals, and antiparasitics, addressing resistant strains and improving treatment outcomes. The growing awareness of the importance of early and appropriate infection treatment also boosts demand. Additionally, expanding healthcare infrastructure in developing regions and increasing accessibility to healthcare services play crucial roles. Supportive government initiatives and funding for infectious disease research further stimulate the market. The increasing occurrence of hospital-acquired infections underscores the need for effective anti-infective agents. Pharmaceutical companies' investment in R&D, strategic partnerships, and collaborations for drug development accelerate the introduction of new and advanced anti-infective agents, driving market growth. However, the emergence of resistant strains and side effects of treatments may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Anti-Infective Agents. The growth and trends of Anti-Infective Agents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Anti-Infective Agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type/Drug Class

  • Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others)
  • Antivirals
  • Antifungals (Azoles, Echinocandins, Polyenes, Others)

By Route of Administration

  • Topical
  • Oral
  • IV
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • E-Commerce
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Anti-Infective Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Anti-Infective Agents market include Pfizer Inc., Abbott, Gilead Sciences Inc., Bristol-Myers Squibb Company, Merck & Co. Inc., Sandoz International GmbH, B. Braun SE, Xellia Pharmaceuticals, Mankind Pharma, Bayer AG, AstraZeneca, Boehringer Ingelheim International GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANTI-INFECTIVE AGENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type/Drug Class
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY TYPE/DRUG CLASS

  • 5.1. Overview By Type/Drug Class
  • 5.2. Historical and Forecast Data Analysis By Type/Drug Class
  • 5.3. Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others) Historic and Forecast Sales By Regions
  • 5.4. Antivirals Historic and Forecast Sales By Regions
  • 5.5. Antifungals (Azoles, Echinocandins, Polyenes, Others) Historic and Forecast Sales By Regions

6. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data Analysis By Route of Administration
  • 6.3. Topical Historic and Forecast Sales By Regions
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. IV Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Specialty Pharmacies Historic and Forecast Sales By Regions
  • 7.6. E-Commerce Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ANTI-INFECTIVE AGENTS COMPANIES

  • 9.1. Anti-Infective Agents Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF ANTI-INFECTIVE AGENTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pfizer Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Abbott
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Gilead Sciences Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Bristol-Myers Squibb Company
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Merck & Co. Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Sandoz International GmbH
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. B. Braun SE
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Xellia Pharmaceuticals
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Mankind Pharma
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Bayer AG
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. AstraZeneca
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Boehringer Ingelheim International GmbH
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type/Drug Class (USD MN)
  • Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others) Market Sales By Geography (USD MN)
  • Antivirals Market Sales By Geography (USD MN)
  • Antifungals (Azoles, Echinocandins, Polyenes, Others) Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • IV Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Specialty Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Anti-Infective Agents Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Anti-Infective Agents Report
  • Market Research Process
  • Market Research Methodology
  • Global Anti-Infective Agents Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type/Drug Class
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type/Drug Class (USD MN)
  • Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others) Market Sales By Geography (USD MN)
  • Antivirals Market Sales By Geography (USD MN)
  • Antifungals (Azoles, Echinocandins, Polyenes, Others) Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • IV Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Specialty Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.